<b>Background/Objectives:</b> Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are increasingly used for the management of obesity and type 2 diabetes, particularly among women of reproductive age. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.